HOME
COMPANY
PRODUCTS
MSDS DATA
LAB PRO.
FAQ
PARA-SITE ONLINE


PRODUCTS

GERMICIDES &
SOAKING TRAYS

ANTISEPTICS

SOAPS & DETERGENTS

ALCOHOLS

STAINS & REAGENTS

Bacteriology
Histology & Cytology
Hematology
Parasitology

FECAL CONCENTRATION
SYSTEMS

FUNGAL
DIAGNOSTIC KITS

Aglutination Systems
Detection / Reagents
Immunodiffusion
Exo-Antigen ID
Fixation Reagents
Culture Media

PRE-FILLED BIOPSY
CONTAINERS


PML Microbiologicals &
QC SYSTEMS


 

 

 

IMMUNO-MYCOLOGICS, INC.
FUNGAL DIAGNOSTIC SYSTEMS AND REAGENTS :

Cryptococcus neoformans Latex Agglutination Systems | Cryptococcus neoformans Tube Agglutination Systems | Sprothrix Scheckii Latex Agglutination Systems and Reagents

CRYPTOCOCCUS NEOFORMANS TUBE AGGLUTINATION SYSTEMS

 

In most cases of cryptococcosis, antigen concentration will exceed antibody and be detected in latex agglutination tests. However, in most cases and in some stages of the disease, antigen may not be present in excess and tests to detect antibody may be necessary to make a serological diagnosis. In Central Nervous System (CNS) cryptococcocis, antigen excess is present and detectable by latex agglutination in spinal fluid in the vast majority of the cases. During successful antifungal therapy, it is not uncommon for antigen tests to become negative and antibody tests to become positive with rising titers. In non-CNS disease (e.g., pulmonary, osteolytic, etc.), antibody tests may be the only means for making a serological diagnosis, since tests for antigen may or may not be positive.

The YA-Crypto Tube Agglutination System is based upon the principle that yeast cells of weakly encapsulated Cryptococcus neoformans strains will agglutinate with specimens containing antibodies against C. neoformans. The system detects these antibodies when present and is both qualitative and semi-quantitative. It is most effective for detecting the antibodies of C. neoformans in the serum of patients with pulmonary and extrapulmonary cryptococcosis (non-meningeal); however, the spinal fluid of cryptococcal meningitis patients may also contain detectable levels of antibody, especially during and following successful therapy.

Cryptococcus Tube Agglutination Systems

PRODUCT NUMBER DESCRIPTION PACKAGING
YA1001 YA-CRYPTO ANTIBODY TUBE AGGLUTINATION SYSTEM 60 Tests

Cryptococcus Tube Agglutination Reagents

PRODUCT NUMBER DESCRIPTION PACKAGING
AC0000 Anti-Cryptococcus Positive Control 2 ml
CW0000 Cryptococcus Yeast Antigen (10X concentrate) 10 ml
GB0020 Glycine Buffered Diluent with Albumin (GBDA, 10X Concentrate) 10 ml
N80010 Negative Control 1 ml
   
Back To:    PRODUCTS    TOP           

 

HOME | COMPANY | PRODUCTS | MSDS DATA | LAB PROCEDURES | FAQ | PARA-SITE ONLINE

© Copyright 2005 Medical Chemical Corporation (MCC). All rights reserved.
Web site developed by Xcite Marketing Services